Manufacturing of Electromedical Electrode Gel

The contract calls for the manufacturing of electrode gel designed to meet stringent military and medical specifications, requiring precise formulation, rigorous batch testing, and comprehensive quality control procedures aligned with both FDA and Defense Logistics Agency standards. Production must adhere to regulatory requirements for safety, efficacy, and consistency, ensuring suitability for use in electromedical applications across defense and healthcare environments. The gel must be produced under controlled conditions with documented adherence to established protocols for raw material sourcing, processing, and final product certification. Performance of this subcontract is designated for Joint Base Andrews, Maryland, with a submission deadline of July 27, 2026, and the solicitation posted on July 20, 2026. The work falls under NAICS code 325412, which classifies it within pharmaceutical and medicine manufacturing. While the specific contracting office details are not fully outlined, the overseeing agency is the Department of Defense through the Medical Supply Chain MD Surg FSF, indicating direct alignment with military medical readiness requirements. The contract emphasizes compliance over commercial volume, prioritizing technical accuracy and regulatory conformity in every stage of production.